IN-001 Sublingual Spray

· Insignis Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IN-001 Sublingual Spray, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: PK/PD Study of IN-001 Sublingual Spray in Healthy Adults [Phase 1]